|
1
|
Izumi K, Shima T, Shigehara K, Sawada K,
Naito R, Kato Y, Ofude M, Kano H, Iwamoto H, Yaegashi H, et al: A
novel risk classification score for malignant ureteral obstruction:
A multicenter prospective validation study. Sci Rep.
11(4455)2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Gadelkareem RA, Abdelraouf AM, El-Taher AM
and Ahmed AI: Acute kidney injury due to bilateral malignant
ureteral obstruction: Is there an optimal mode of drainage? World J
Nephrol. 11:146–163. 2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Hugar LA, Wulff-Burchfield EM, Winzelberg
GS, Jacobs BL and Davies BJ: Incorporating palliative care
principles to improve patient care and quality of life in urologic
oncology. Nat Rev Urol. 18:623–635. 2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Cordeiro MD, Coelho RF, Chade DC, Pessoa
RR, Chaib MS, Colombo-Júnior JR, Pontes-Júnior J, Guglielmetti GB
and Srougi M: A prognostic model for survival after palliative
urinary diversion for malignant ureteric obstruction: A prospective
study of 208 patients. BJU Int. 117:266–271. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Brin EN, Schiff M Jr and Weiss RM:
Palliative urinary diversion for pelvic malignancy. J Urol.
113:619–622. 1975.PubMed/NCBI View Article : Google Scholar
|
|
6
|
National Institute for Health and Care
Excellence (NICE): Bladder cancer: diagnosis and management. NICE
guideline, Ref. no. NG2, Published 25 February 2015. https://www.nice.org.uk/guidance/ng2.
Accessed Jan 14, 2024.
|
|
7
|
Felice MD, Koehne EL, Patel HD, Elliott N,
Hekman L, Lewer O, Jarrard DF, Nichols K, Risk MC, Richards KA, et
al: The current status of palliative care, hospice, and end-of-life
health care utilization in patients with malignant ureteral
obstruction. Urol Pract. 11:187–196. 2024.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Artiles Medina A, Laso García I, González
Tello F, Álvarez Rodríguez S, Hevia Palacios M, Mata Alcaraz M,
Mínguez Ojeda C, Arias Funez F, Gómez Dos Santos V and Burgos
Revilla FJ: The challenging management of malignant ureteral
obstruction: Analysis of a series of 188 cases. Curr Urol.
18:34–42. 2024.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Dhani FK, Daryanto B and Seputra KP:
Survival outcome of urinary diversion in advanced cervical cancer
patients with hydronephrosis. Asian Pacific J Cancer Prev.
24:2641–2646. 2023.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Carmona O, Shvero A, Zilberman DE, Dotan
ZA and Kleinmann N: Unveiling the challenges in tandem ureteral
stent management for malignant ureteral obstruction: Failure rate,
risk factors, and durability of their replacement. J Clin Med.
12(5251)2023.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Heo JE, Jeon DY, Lee J, Ham WS, Choi YD
and Jang WS: Clinical outcomes after urinary diversion for
malignant ureteral obstruction secondary to Non-urologic cancer: An
analysis of 778 cases. Ann Surg Oncol. 28:2367–2373.
2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Liu KL, Lee BC, Ye JD, Chang YH, Chang CC,
Huang KH, Lee YJ and Chang YC: Comparison of single and tandem
ureteral stenting for malignant ureteral obstruction: A prospective
study of 104 patients. Eur Radiol. 29:628–635. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Asakawa J, Iguchi T, Tamada S, Ninomiya N,
Kato M, Yamasaki T and Nakatani T: Treatment outcomes of ureteral
stenting for malignant extrinsic ureteral obstruction: A comparison
between polymeric and metallic stents. Cancer Manag Res.
10:2977–2982. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ohtaka M, Kawahara T, Takamoto D,
Mochizuki T, Hattori Y, Teranishi JI, Makiyama K, Miyoshi Y, Yumura
Y, Yao M and Uemura H: Gastrointestinal cancer and bilateral
hydronephrosis resulted in a high risk of ureteral stent failure.
BMC Urol. BMC Urol. 18(35)2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Schönberg SO, Budjan J and Hausmann D:
Urinary obstruction, stone disease, and infection. Chapter 23. In:
Diseases of the Abdomen and Pelvis 2018-2021: Diagnostic
Imaging-IDKD Book. Hodler J, Kubik-Huch RA and von Schulthess GK
(eds). Springer, Cham, 2018.
|
|
16
|
Haas CR, Shah O and Hyams ES: Temporal
trends and practice patterns for inpatient management of malignant
extrinsic ureteral obstruction in the United States. J Endourol.
34:828–835. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Tabib C, Nethala D, Kozel Z and Okeke Z:
Management and treatment options when facing malignant ureteral
obstruction. Int J Urol. 27:591–598. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Misra S, Coker C and Richenberg J:
Percutaneous nephrostomy for ureteric obstruction due to advanced
pelvic malignancy: Have we got the balance right? Int Urol Nephrol.
45:627–632. 2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Gauhar V, Pirola GM, Scarcella S, De
Angelis MV, Giulioni C, Rubilotta E, Gubbiotti M, Lim EJ, Law YXT,
Wroclawski ML, et al: Nephrostomy tube versus double J ureteral
stent in patients with malignant ureteric obstruction. A systematic
review and meta-analysis of comparative studies. Int Braz J Urol.
48:903–914. 2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Hsu L, Li H, Pucheril D, Hansen M,
Littleton R, Peabody J and Sammon J: Use of percutaneous
nephrostomy and ureteral stenting in management of ureteral
obstruction. World J Nephrol. 5:172–181. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Yuri P and Rochadi S: Percutaneus
nephrostomy in patients with obstructive uropathy due to
malignancy: A survival analysis. Indones J Urol. 23:108–112.
2016.
|
|
22
|
Lapitan MCM and Buckley BS: Impact of
palliative urinary diversion by percutaneous nephrostomy drainage
and ureteral stenting among patients with advanced cervical cancer
and obstructive uropathy: A prospective cohort. J Obstet Gynaecol
Res. 37:1061–1070. 2011.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Prentice J, Amer T, Tasleem A and
Aboumarzouk O: Malignant ureteric obstruction decompression: How
much gain for how much pain? A narrative review. J R Soc Med.
111:125–135. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Pradhan TS, Duan H, Katsoulakis E, Salame
G, Lee YC and Abulafia O: Hydronephrosis as a prognostic indicator
of survival in advanced cervix cancer. Int J Gynecol Cancer.
21:1091–1096. 2011.PubMed/NCBI View Article : Google Scholar
|
